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Abstract
Background: The Forkhead box O (FOXO) class of transcription factors are involved in the regulation of several cellular
responses including cell cycle progression and apoptosis. Furthermore, in model organisms FOXOs act as tumor suppressors
and affect aging. Previously, we noted that FOXOs and p53 are remarkably similar within their spectrum of regulatory
proteins [1]. For example, the de-ubiquitinating enzyme USP7 removes ubiquitin from both FOXO and p53. However, Skp2
has been identified as E3 ligase for FOXO1, whereas Mdm2 is the prime E3 ligase for p53.
Principal Findings/Methodology: Here we provide evidence that Mdm2 acts as an E3 ligase for FOXO as well. In vitro
incubation of Mdm2 and FOXO results in ATP-dependent (multi)mono-ubiquitination of FOXO similar to p53. Furthermore,
in vivo co-expression of Mdm2 and FOXO induces FOXO mono-ubiquitination and consistent with this result, siRNA-
mediated depletion of Mdm2 inhibits mono-ubiquitination of FOXO induced by hydrogen peroxide. Regulation of FOXO
ubiquitination by Mdm2 is likely to be direct since Mdm2 and FOXO co-immunoprecipitate. In addition, Mdm2-mediated
ubiquitination regulates FOXO transcriptional activity.
Conclusions/Significance: These data identify Mdm2 as a novel E3 ligase for FOXOs and extend the analogous mode of
regulation between FOXO and p53.
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Introduction
Forkhead box O (FOXO) transcription factors have recently
gained considerable attention because of their potentially critical
role in aging [1,2]. The paradigm in this respect is the C. elegans
FOXO ortholog DAF-16. Lifespan extension through a number of
genetic and non-genetic interventions in these nematodes requires
at least in part DAF-16 [2]. Especially, the effects of lowered
insulin signaling critically depend on DAF-16 and DAF-16 acts
downstream of the insulin signaling pathway consisting of the lipid
kinase phosphoinositide-3 kinase (PI-3K) and the serine/threonine
protein kinase B (PKB/AKT). PKB directly phosphorylates DAF-
16/FOXO and this results in nuclear exclusion and therefore
reduced DAF-16/FOXO transcriptional activity [3,4].
Aging may also result from the accumulating damage caused by
reactive oxygen species (ROS)[5]. In this respect regulation of
cellular anti-oxidant capacity by DAF-16/FOXO provided
rationale for its effect on lifespan. Interestingly, FOXO itself is
also regulated by ROS and treatment of cells with hydrogen
peroxide, which increases cellular oxidative stress, results in
nuclear translocation of FOXO [6,7]. FOXOs are regulated
through a multitude of post-translational modifications (PTMs)
including phosphorylation, acetylation and ubiquitination (re-
viewed in [1]). Whereas PKB-mediated phosphorylation results in
exclusion of FOXO from the nucleus, the mechanism and/or
PTMs responsible for relocalization to the nucleus after increased
cellular oxidative stress, remain poorly understood. However, the
enzymes responsible for adding these modifications are remark-
ably similar between p53 and FOXO (for a discussion see [1]).
With respect to the regulation of ubiquitination we previously
identified USP7 as a de-ubiquitinating enzyme for FOXO4 [8]
and USP7 is also a de-ubiquitinating enzyme for p53 [9]. FOXOs
are relatively stable proteins with a half-life of approximately 8–
10 hrs in untransformed cells [8]. In transformed/oncogenic cells,
especially cells transformed through activation of PI-3K signaling,
FOXO protein half-life is shortened [10–12]. This is likely due to
PI-3K/PKB mediated upregulation of Skp2 in these cells, as Skp2
has been identified as an ubiquitin E3 ligase responsible for
FOXO poly-ubiquitination and degradation [10]. Consistent with
Skp2 regulation by PKB and FOXO being degraded in a Skp2-
dependent manner, several other PKB targets have been reported
to be degraded in a Skp2-dependent manner as well [11,13].
Previously, we demonstrated that the signaling function of
FOXO4 is regulated by mono-ubiquitination especially after
increased cellular oxidative stress [8]. Mono-ubiquitination
correlates with increased nuclear localization of FOXO and
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expression inhibited FOXO4 transcriptional activity due to de-
ubiquitination of FOXO4 and re-localization to the cytosol. To
further understand the regulation of mono-ubiquitination of
FOXOs we searched for ubiquitin E3 ligases that would ligate
ubiquitin onto FOXO4. Here, we report the identification of
Mdm2 as an E3 ligase for FOXO4 that mediates mono-
ubiquitination of FOXO4 after increased cellular oxidative stress.
Results
In our attempt to identify potential E3 ligases for FOXOs we
co-expressed several candidate E3 ligases with FOXO and noticed
that Mdm2 co-expression resulted in an apparent reduction in
FOXO4 expression (Fig. 1a). In transient expression experiments
reduced protein expression can occur through various mechanisms
including promoter squelching. However, as Mdm2 induces
ubiquitin-mediated breakdown of target proteins we first analyzed
whether Mdm2 could catalyze ubiquitin addition to FOXO4 in
vitro. To this end we reconstituted a functional E1-E2-Mdm2
ubiquitin ligase system using purified proteins and added GST-
FOXO4 as a substrate. Only in the presence of rATP this resulted
in the addition of multiple ubiquitin moieties to GST-FOXO
causing a laddering indicative for poly-ubiquitination or multiple
mono-ubiquitination (Fig. 1b). Importantly, this in vitro reconsti-
tuted system displayed similar activity towards GST-p53, but not
to GST alone, suggesting that in vitro FOXO is as good a substrate
for Mdm2 as is p53. Mdm2 uses a C-terminal RING finger
domain, critical to its function as an E3-Ligase. A Mdm2 mutant
lacking this domain was tested and found unable to ubiquitinate
FOXO4 (Fig. 1b), highlighting the specificity of Mdm2 and the
dependency on its E3-ligase activity to mono-ubiquitinate FOXO4
in vitro. To further address whether the in vitro observed laddering
represents poly-ubiquitination or multiple mono-ubiquitination, a
number of ubiquitin mutants instead of wild-type ubiquitin were
analyzed in the in vitro ubiquitination assay. Using ubiquitin-K48A,
defective in K48-mediated ubiquitin branching which targets
proteins for the proteasome, and ubiquitin-K7R and methyl-
ubiquitin both defective in mediating poly-ubiquitination all
resulted in same pattern of mdm2-mediated GST-FOXO
laddering (Fig 1c). Taken together these results clearly show that
in an in vitro reconstituted system Mdm2 can act as an E3-ligase for
FOXO4 and that in contrast to what has been reported for p53,
Mdm2 catalyzes multiple mono-ubiquitination of GST-FOXO4
rather than poly-ubiquitination.
Next, we tested whether Mdm2 also can ubiquitinate FOXO4
in vivo. Co-expression of flag-FOXO4 and myc-Mdm2 induced
mono-ubiquitination of FOXO4 (Fig. 1d). We did not observe
substantial poly-ubiquitination, also not in the presence of the
proteasome inhibitor MG132 (data not shown). Also, the delta-
RING domain Mdm2 mutant did not induce FOXO4 mono-
ubiquitination (Fig 1e). Albeit consistent with our in vitro data this
Figure 1. FOXO4 is a substrate for Mdm2 ubiquitination. (a) Mdm2 co-expression decreases FOXO protein levels. FOXO4 and Mdm2 were co-
expressed in HEK293T cells. Cell lysates were probed by western blot analysis as indicated. (b) Mdm2 ubiquitinates FOXO4 and p53 in vitro with
similar stoichiometry. Purified Mdm2 or Mdm2-delta-RING was incubated with GST-FOXO4, GST-p53 or GST alone, together with Ubiquitin and E1-E2-
in vitro recombinant proteins. Ubiquitination was measured 2 h., after addition of rATP. (c) FOXO4 is multi-mono-ubiquitinated by Mdm2. The
experiment was performed as in (b), using ubiquitin proteins (Ubi-K48A, Methylated Ubiquitin and Ubi-K7R) that are unable to poly-ubiquitinate. (d)
Mdm2 ubiquitination of FOXO in vivo. HEK293T cells were transfected with myc-Mdm2, Flag-FOXO4 or control vector together with His-Ubiquitin.
After 24 h, cells were treated with 50 mMH 2O2 for 15 min, and subjected to a ubiquitination assay (see Methods) (e) FOXO4 mono-ubiquitination in
vivo depends on the Ring finger of Mdm2. HEK293T cells were transfected with indicated constructs and subjected to a ubiquitination assay. (f)
Mdm2 mediated FOXO4 downregulation is MG132 insensitive. MCF7 cells were transfected with the indicated constructs and treated with MG132 o/
n. (g) FOXO4 mono-ubiquitination is dependent on Mdm2. HEK293T cells were treated with either control (c) or human Mdm2 RNAi and
subsequently transfected with His-Ubiquitin and HA-FOXO. Cells were treated with 50 mMH 2O2 for 15 min and subjected to a ubiquitination assay.
doi:10.1371/journal.pone.0002819.g001
Mdm2 Induces FOXO4 Mono-Ubi
PLoS ONE | www.plosone.org 2 July 2008 | Volume 3 | Issue 7 | e2819questions the mechanism underlying the reduced detection of
FOXO4 protein by immunoblotting after overexpression of
Mdm2. Reduced detection of FOXO4 concomitant with Mdm2
overexpression would normally be taken to indicate proteasomal
degradation of FOXO4 and this should be reversed by MG132
treatment. However, we did not observe substantial rescue of
FOXO4 protein expression after MG132 treatment, despite
observing accumulation of auto-poly-ubiquitinated Mdm2 species,
which indicates that the MG132 treatment did work (Fig. 1f).
Again this is consistent with the observed lack of poly-ubiquitina-
tion and suggests that either FOXO4 is degraded through another
pathway for example caspase-mediated breakdown, or alterna-
tively, that (multiple) mono-ubiquitinated FOXO4 is targeted to a
cellular compartment for example PML bodies from which it is
not efficiently extracted. To confirm our MG132 experiments, we
performed FOXO4 half-life studies. Transfection of Mdm2 did
not affect the half-life of co-transfected FOXO4 (Supplementary
Fig. S1). Taken together these results indicate that Mdm2
expression does not lead to FOXO4 degradation by means of
regulating its protein stability through the proteasome. This
finding is consistent with our MG132 experiments. Thus in all
approaches we come to the conclusion that Mdm2 does not
substantially affect FOXO4 protein half-life.
Finally, to further substantiate a role for endogenous Mdm2 in
regulating the ubiquitin status of FOXO4 in vivo, we used siRNA
against the human ortholog of Mdm2 (Supplementary Fig. S2). As
reported previously, increasing cellular oxidative stress by treating
cells with hydrogen peroxide induced mono-ubiquitination of both
FOXO4 and FOXO3a [8] and Supplementary Fig. S3.I m p o r -
tantly, siRNA-mediated knockdown of Mdm2 significantly reduced
hydrogen peroxide-induced mono-ubiquitination of FOXO4
(Fig. 1h). Together, these data provide compelling evidence that
Mdm2 can mediate FOXO4 mono-ubiquitination in vitro and in vivo.
To test the possibility that Mdm2 could directly regulate FOXO
we analyzed binding between Mdm2 and FOXO4. Upon co-
expression of Flag-Mdm2 and HA-FOXO4, FOXO4 was co-
immunoprecipitated with Mdm2, and vice-versa (Fig. 2a,b).
Consistent with our in vitro data, this result suggests that Mdm2
directly binds and regulates FOXO4, rather than through
regulating the activity of de-ubiquitinating enzymes such as
USP7. Next, we tested binding between endogenous FOXO4
and Mdm2 proteins and observed reciprocal co-immunoprecip-
Figure 2. Mdm2 interacts with FOXO4. (a) HA-FOXO4 and Flag-Mdm2 were co-expressed in HEK293T cells, co-immunoprecipitated for Flag and
probed as indicated. (b) HEK293T cells were transfected with Flag-FOXO4 and Myc-Mdm2. Lysates were co-immunoprecipitated with Flag antibody
and proteins were detected as indicated. (c) FOXO4 and Mdm2 interact in vivo. HEK293T cells were immunoprecipitated for FOXO4, Mdm2 or isotype
controls (c) and probed as indicated. Prior to Co-Ip, cells were treated for 15 min. with 200 mM hydrogen peroxide.
doi:10.1371/journal.pone.0002819.g002
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cells (Fig 2c). Mono-ubiquitination of FOXO4 results in increased
transcriptional activity of FOXO4 [8] and this is reversed by USP7-
mediated de-ubiquitination. To see whether Mdm2 would also
regulate FOXO4 transcriptional activity we performed FOXO
reporter assays. Expression of increasing amounts of Mdm2 resulted
in a bell-shaped regulation of FOXO4 transcriptional activity. Low
amounts of Mdm2 transfected induced a reproducible increase in
FOXO4 transcriptional activity on two different FOXO responsive
reporters (Fig. 3a (6xDBE-luciferase) and Fig. 3b (p27-luciferase)),
consistent with the notion that Mdm2 can induce mono-ubiquitina-
tion of FOXO4. In contrast, higher amounts of Mdm2 transfected
resulted in reduced FOXO4 transcriptional activity. This suggests
that the multiple mono-ubiquitination of FOXO4 induced by
Mdm2 in vitro and possibly in vivo by high levels of Mdm2 represents
inactivation of FOXO4. In effect this would be similar to poly-
ubiquitination and degradation, but in contrast this leaves FOXO4
to be re-activated by de-ubiquitination by USP7 [8]. To assess the
structural requirements of Mdm2 to regulate FOXO4 transcrip-
tional activity we compared the effect of wild-type Mdm2 on
FOXO4 transcriptional activity with that of Mdm2 mutated in its
RING domain, and with that of Mdm2 mutated in its p53
interaction domain (Fig. 3c). The RING domain mutant of Mdm2
did not affect FOXO4 transcriptional activity indicating that Mdm2
regulated FOXO4activityrequiresafunctionalE3ligasedomain.In
contrast, p53 binding to Mdm2 appears not involved as Mdm2
defective in binding to p53 regulated FOXO4 in a manner identical
to wild-type Mdm2. Ectopic expression of FOXO4 in cells induces
cell cycle arrest and induction of apoptosis [1] and this can be
monitored by a reduction in colony formation ([14] and Fig 3d).
Similartodecreased transcriptionalactivityathigherlevelsof Mdm2
co-expression Mdm2 represses the ability of FOXO4 to inhibit
colony formation.
Discussion
Here we provide evidence that Mdm2 is an E3-ligase that can
ligate ubiquitin onto FOXO4 both in vitro and in vivo.M o n o -
ubiquitination of FOXO4 as induced by hydrogen peroxide
treatment of cells requires endogenous Mdm2, because siRNA
mediated knockdown of Mdm2 prevents mono-ubiquitination. This
shows that Mdm2 is at least functional in regulating mono-
ubiquitination of FOXO4. In vitro, Mdm2 induces a pattern of
ubiquitination that normally is considered indicative of poly-
ubiquitination. However, alternative to poly-ubiquitination, exten-
sive mono-ubiquitination on multiple different lysine residues, 19 of
which are present in FOXO4, can cause a similar characteristic
laddering. This would be consistent with the current view that low
mobility species of ubiquitinated p53 represent mono-ubiquitinated
p53 (Fig. 1 and [15,16]. To further discriminate between these
possibilitiesweuseda numberof ubiquitin mutantsthatare defective
in poly-ubiquitination (K48A, K7R and methyl-ubiquitin).
Figure 3. Mdm2 regulates FOXO4 activity. (a, b) Mdm2 regulates FOXO activity in a bell-shaped manner. MCF7 cells were transfected with
indicated constructs, TK-Renilla and either a luciferase construct with 6 perfect FOXO4 DNA binding elements (6xDBE) (a) or a luciferase construct
under the control of the endogenous p27
kip1 promoter (b). Representative data are shown as mean6s.d. of triplicates. The significance of changes in
the lanes with Mdm2 as compared to wild-type FOXO (lane 2) was confirmed by t-test (**p,0.005). (c) FOXO regulation of Mdm2 is independent of
p53 but dependent on its RING finger activity. Luciferase activity was measured in MCF7 cells, 24 h after transfection with indicated constructs, TK-
Renilla and (6xDBE). (d) FOXO mediated cell cycle arrest is blocked by Mdm2. A14 cells were transfected by indicated constructs together with
pbabePuro. Colony outgrowth of puromycin selected cells was monitored after 10 days.
doi:10.1371/journal.pone.0002819.g003
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vitro assay, Mdm2 catalyzed a highly similar, if not identical,
pattern of laddering compared to including wild-type ubiquitin in
this assay. This strongly suggests that in vitro Mdm2 catalyzes
preferentially only (multi-)mono-ubiquitination of GST-FOXO4.
Also in vivo overexpression or siRNA-mediated knockdown of
Mdm2 resulted in the induction or loss of FOXO4 mono-
ubiqitination respectively. Thus we conclude that Mdm2 regulates
mono-ubiquitination of FOXO4. However, we observed an
apparent reduction in protein expression of FOXO4, especially
after high expression of Mdm2 and this would suggest protein
degradation most likely through poly-ubiquitination-mediated
proteasomal degradation. This would be at odds with the
conclusion that Mdm2 catalyzes mono-ubiquitination. To estab-
lish whether proteasomal degradation is causal to the reduced
detection of HA-FOXO4 after flag-Mdm2 overexpression we
treated cells with MG132. Inhibition of proteasome-mediated
degradation did not result in increased detection of HA-FOXO4
despite observed accumulation of Mdm2. Thus, this result does
not implicate Mdm2 induced poly-ubiquitination of HA-FOXO4
and subsequent degradation through the proteasome and is
consistent with the lack of effect of MG132 treatment on FOXO4
ubiquitination in vivo (Fig 1, and B.M.T.B, unpublished data).
Consistent with these observations, protein stability experiments
indicate that Mdm2 does not affect FOXO4 protein stability.
Consequently, reduced detection of FOXO4 after Mdm2
overexpression is likely due to other mechanism(s). This could be
alternative mechanism(s) of degradation such as lysosomal
degradation or protease-mediated degradation (e.g. caspase).
Alternatively, mono-ubiquitination has been shown in several
cases to regulate cellular localization of proteins and thus the
apparent reduction in protein expression may equally represent a
shift of target protein into a complex or towards a cellular location
that results in inefficient extraction of protein and thereby reduced
detection after immunoblotting. Indeed, recent developments have
provided multiple examples in different signaling pathways that
ubiquitination serves other purposes than merely targeting
proteins for degradation [17–19]. This raises the interesting
possibility that the initial function of (mono-)-ubiquitination is to
provide a means to regulate protein function similar to for
example phosphorylation. However, to terminate the signaling
function of (mono-)ubiquitination a cell can choose between either
de-ubiquitination or poly-ubiquitination. Depending on the
urgency to terminate signaling, poly-ubiquitination and subse-
quent degradation, may be the preferred mode.
While our study was in progress Yang et al. also reported
ubiquitination of FOXO3a by Mdm2 [20]. However, in contrast
to our results presented here, their study suggests a role for Mdm2
mainly in the breakdown of FOXO3a. As discussed above, in our
experiments only high expression of Mdm2 may result in induced
breakdown of FOXO4.
Yang et al. also implicated a role for ERK in the regulation of
FOXO3a by Mdm2 and provide evidence that FOXO3a
phosphorylation by ERK through an unknown mechanism
induces Mdm2 binding to FOXO3a [20]. Importantly, Yang et
al. use EGF as stimulus whereas we use peroxide stress. It is of
importance to note that the stimuli used by others (EGF, PDGF,
insulin) all inhibit FOXO function whereas we and others have
shown that oxidative stress (e.g. peroxide) as used here activates
FOXOs [6]. This is an essential difference. In addition, for PDGF
and insulin stimulation several previous studies have shown that
Skp2 is involved in degradation of FOXO induced by these factors
[10,11]. In addition, with respect to the issue here, several
interesting observations within these studies were made. Firstly,
FOXO half-life in ‘normal’ cells is around 8–10 hrs similar to our
previous observations ([8] and the results in this study). Second,
only in cells transformed through PI3K activation (v-Ha-RAS,
Active PI3K alleles) FOXO half-life is shortened [21], but again
this is in these studies a PKB/AKT and Skp2 mediated process
(and not ERK-Mdm2). We are tempted to speculate that Mdm2
induces FOXO mono-ubiquitination; this results in activation of
FOXO. Activation can be terminated by USP7 de-ubiquitination
or alternatively by Skp2-mediated poly-ubiquitination and degra-
dation. The latter occurs as a result of oncogenic transformation
through PI3K/PKB/AKT, but possibly also through ERK
signalling. Thus if one considers the possibility of Mdm2 being a
‘priming’ E3-ligase for FOXO and Skp2 the branching E3-ligase,
these different results can be reconciled. Clearly further studies are
required to fully appreciate the role of ubiquitination in FOXO
regulation in response to various cellular conditions.
Mono-ubiquitination is observed and studied thus far, for
proteins with a relative long half-life, such as PTEN [22], EGF
receptor [23] and FOXOs (approximately 10 hrs in untrans-
formed cells [8]). In contrast, mono-ubiquitination has not yet
been considered for short lived proteins such as cell cycle
regulators (cyclins) and oncogenes (myc, beta-catenin). However,
establishing mono-ubiquitination for these short-lived proteins
may just be a technical challenge. Indeed, recent results with p53
may provide basis for such a paradigm shift. Whereas, initially p53
served as a classical example of a protein regulated through
protein degradation, it is by now clear that mono-ubiquitination of
p53 occurs and serves to provide a new signaling function to p53
[15,24]. Instead of acting as a transcription factor, mono-
ubiquitination of p53 serves as a signal to relocate p53 from the
nucleus to mitochondrial membrane [24]. Along the same line of
reasoning, the role of Mdm2 in ubiquitination of p53 is now being
discussed [17,25,26]. Thus, the possibility is being raised that
endogenously expressed Mdm2 is actually preferentially involved
in mono-ubiquitination of p53, whereas aberrant high expression
of Mdm2 may result in poly-ubiquitination and degradation of
p53. Essentially, our observations presented here indeed fully
support a role for Mdm2, at endogenous level, in regulating mono-
ubiquitination of in this case FOXO4.
In summary, we have identified Mdm2 as an ubiquitin E3 ligase
for FOXO4 which functions in oxidative stress-induced FOXO4
mono-ubiquitination. This extends the network of co-regulatory
proteins of FOXO and p53 and therefore supports a model of co-
evolution of stress maintenance mechanisms.
Materials and Methods
Cell culture and Transfection
HEK293T, MCF7 and A14 cells (3T3 fibroblasts stably
expressing the insulin receptor) were maintained in Dulbecco’s
Modified Eagle medium (Cambrex), supplemented with 10% fetal
bovine serum, penicillin/streptomycin and 0.05% glutamine.
Transient transfections were performed with FuGENE6 (Roche).
Cycloheximide experiments were performed as described [8]
Constructs, antibodies and RNAi
pMT2-HA-FOXO4 and pMT2-Flag-FOXO4, His-Ubiquitin,
Flag-Mdm2, the inactive Mdm2 RING-finger mutant C464A, Myc-
Mdm2-delta-RING domain, MycMDM2-delta-p53 mutants and
Myc-Mdm2 have been described previously [8,27]. The luciferase
constructsTK-Renilla,6xDBEandthep27
kip1Luciferasepromoters
have been described [6]. Non-targeting RNAi duplex (c), RNAi
smartpool oligonucleotides specific for human Mdm2 were pur-
chased from Dharmacon. Cells were transfected with 20 mMR N A i
Mdm2 Induces FOXO4 Mono-Ubi
PLoS ONE | www.plosone.org 5 July 2008 | Volume 3 | Issue 7 | e2819with Oligofectamine (Invitrogen) for RNAi oligonucleotides and
FuGENE6 for DNA constructs. DNA constructs were transfected
8 h. after the last RNAi oligonucleotide transfection. The antibodies
against FOXO4 (834) and HA (12CA5), have been described [4].
The following antibodies were purchased; Mdm2 (SMP-14, Santa
Cruz), Tubulin and Flag-M2 (Sigma).
Co-immunoprecipitation assay
For co-immunoprecipitation studies, 50 ml Protein-A Sepharose
beads were pre-coupled to 1 mg of the indicated antibody. Cells
were lysed in Co-IP buffer (20 mM Tris-HCl pH 8.0, 1% NP-40,
10% glycerol, 1 mM MgCl2, 1 mM EDTA, 150 mM NaCl,
protease and phosphatase inhibitors) and incubated as described
previously [28]. For endogenous co-immunoprecipitations, cells
were treated prior to lysis with hydrogen peroxide (200 mM,
15 min.).
Luciferase Reporter assay
Cells were transfected with the indicated constructs plus 20 ng
TK-Renilla per condition as a transfection efficiency control.
Lysates were measured after 24 h by the Promega Dual Luciferase
reporter assay.
Ubiquitination assays
The in vitro ubiquitination assay was performed essentially as
described [29]. Flag-Mdm2 was purified from HEK293T cells
with Flag-M2 beads (Sigma). Precipitated protein was washed with
RIPA, and eluted off with Flag peptide (Sigma). Eluted protein was
dialysed o/n with a buffer containing (25 mM HEPES-pH 8.0,
150 mM NaCl, protease inhibitors). The in vitro ubiquitination
assay was initiated with the addition of ATP (f.c.2.5 mM) and
quenched after 2 h with Laemmli Sample Buffer. Purified GST
and GST-FOXO4 were a kind gift from H. de Ruiter. Purified
GST-p53, E1, E2 (UbcH5b) were kind gifts from Dr. K.W.
Mulder. Ubiquitin, Ubiquitin-K7R (All lysines mutated to
arginine), Ubiquitin-K48A (lysine 48 mutated to Alanine) and
methylated Ubiquitin (all lysines methylated) were purchased at
Boston Biochem. In vivo ubiquitination assays were essentially
performed as described [8]. In brief, HEK293T cells were
transfected with the indicated constructs. 48 h. post transfection,
cells were left untreated or treated as indicated, and lysed in lysis
buffer (8 M Urea, 10 mM Tris-HCl pH 8.0, 100 mM Na2HPO4/
NaH2PO4, 0.2% TX-100, 5 mM NEM, protease inhibitors).
Ubiquitinated proteins were precipitated using Ni-NTA agarose
beads and analysed by WB.
Colony outgrowth assay
Equal amounts of A14 cells were plated in triplicate in 6-well
dishes and transfected with 2 mg of the indicated constructs in
combination with 0.5 mg pbabe-puro. 24 hours post-transfection
cells were placed under selection with 2 mg/ml Puromycin. Every
two days the selection medium was refreshed. At 10 days post
transfection cells were fixed for 10 minutes with ice-cold methanol
and colonies were stained with 0.5% crystal violet, dissolved in
25% methanol. The plates were washed with dH2O and dried
overnight.
Supporting Information
Figure S1 FOXO4 protein stability is not affected by Mdm2.
MCF7 were transfected with either FOXO4 alone, or in
combination with Mdm2. Transfected cells were treated with
cycloheximide (CHX) for indicated times. Relative protein
expression levels were quantified and displayed in a graph
(bottom)
Found at: doi:10.1371/journal.pone.0002819.s001 (0.88 MB TIF)
Figure S2 Efficient knockdown of human Mdm2 by RNAi.
Found at: doi:10.1371/journal.pone.0002819.s002 (0.79 MB TIF)
Figure S3 Mono-ubiquitination of FOXO4 and FOXO3a is
induced upon peroxide stress. HEK293T cells were transfected
with indicated constructs and His-Ubiquitin. Cells were left
untreated or were treated with 50 mM H2O2 for 30 min, lysed
and subjected to a ubiquitination assay. (*) Ubiquitinated FOXO4,
(**) Ubiquitinated FOXO3a.
Found at: doi:10.1371/journal.pone.0002819.s003 (1.21 MB TIF)
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